• Q1 revenue of $19.3B beat guidance by $211M (+1.1%) and consensus by $49M (+0.3%). The Q1 beat was modest — the real story was what came next.
• Q2 revenue guidance of $22.0B obliterated consensus by $1.5B (+7.2%). AI semiconductor revenue guided to $10.7B in Q2 (+140% Y/Y), accelerating from Q1's +106%. This was the most consequential data point of the print.
• "Line of sight to AI chip revenue in excess of $100 billion in 2027." The single most aggressive forward revenue commitment in Broadcom's history — and arguably in semiconductor history. Stacy Rasgon's reverse-engineering confirmed ~10 GW of compute across 6 customers.
• OpenAI named as the 6th XPU customer — deploying first-gen XPU in volume 2027 with >1 GW of compute capacity. Reduces customer concentration risk and adds the highest-profile AI company to the AVGO platform.
• Meta MTIA proactively defended: "Alive and well, shipping now, multiple GW in 2027 and beyond." Hock pre-scripted this defense to address the single biggest bear case overhang.
• Gross margin narrative reversed 180°. Q4's Kirsten: "margins will come down." Q1's Hock: "you must be a bit hallucinating." Non-GAAP GM of 77.0% beat guided decline by ~100 bps. Either the margin math genuinely improved or management is staking credibility on a bold call.
• Supply chain secured through 2028. Extended from prior "through 2026" — the strongest forward supply visibility statement in the company's history. Charlie Kawwas confirmed 2028 growth with a simple "Yes."
• AI networking accelerating to 40% of AI revenue in Q2 (from 33% in Q1). Broadcom now claims to be "the largest networking company" — Tomahawk 6 at 100 Tbps capturing share regardless of GPU vs XPU architecture.
• Stock gapped +4.8% on D+1, outperforming SOX by +5.97%. D+2 hit an intraday high of $343.51 (+8.2% from pre-print) before fading. The market awarded the forward guidance, not the Q1 beat. FY2027 consensus EPS jumped +17.0% in 4 weeks.
• Estimates revised massively: FY2027 revenue +$16.9B (+12.6%), EPS +$2.42 (+17.0%). The stock at 25.7x NTM and 19.9x FY2027 EPS trades at a discount to the growth profile. 95% of analysts are Buy-rated with a median PT of $470 (42% upside).

• $100B+ AI chip revenue target for FY2027 — reframes Broadcom from a $20B AI business to a company with credible line of sight to $100B+ in chips alone. At ~10 GW × $10-20B/GW across 6 customers, the math checks out. This reset the medium-term earnings power debate.
• Q2 AI semiconductor guidance of $10.7B (+140% Y/Y) — growth accelerating, not decelerating. The step-up from $8.4B to $10.7B in one quarter is the hallmark of hyper-growth that re-rates multiples.
• OpenAI as 6th named XPU customer with >1 GW in 2027 — expands the customer base and adds the most prominent AI company. Validates the custom silicon thesis against the "everyone will use GPUs" narrative.
• Meta MTIA alive and well — proactively addressing the single biggest bear case overhang with specifics. Credibility depends on Meta confirming from their side.
• Gross margin reversal — from explicit Q4 warning of margin compression to Q1's "you're hallucinating." Kirsten walked back her own prior commentary. If margins hold, this removes the most significant earnings quality concern.
• Supply chain locked through 2028 — 2-year extension of stated visibility. TSMC wafers, HBM, substrates all secured. This is a structural competitive advantage that limits downside.
• AI networking growing to 40% of AI revenue — broadens AVGO from "just an ASIC house" to a full-stack AI data center supplier. Networking is higher margin than pass-through HBM costs and validates Tomahawk 6.

• The Q2 revenue guide of $22.0B was $1.475B above pre-earnings consensus — a 7.2% upside surprise that triggered the massive estimate revisions. Post-earnings Q2 consensus of $21.7B is still $337M below company guidance, suggesting further upside.
• AI semiconductor guided to $10.7B in Q2 (+140% Y/Y), accelerating from Q1's +106%. AI will be 72% of semiconductor revenue (up from 67%).
• AI networking expected to grow to 40% of total AI revenue in Q2 (from 33% in Q1), implying ~$4.3B — an independent franchise-scale business.
• Guidance framework expanded dramatically: from Q-only to an 18-month forward $100B+ AI chip target. Most aggressive posture in company history.
• Post-earnings Q2 consensus: Revenue $21.7B, EPS $2.34 — both still below company guidance trajectory.

FY2027 estimate revisions are extraordinary — Street revenue moved up $16.9B (+12.6%) and EPS up $2.42 (+17.0%) in 4 weeks. This is directly driven by Hock's $100B+ AI chip target and the 6th customer disclosure. Q2 consensus is still $337M below company guidance, suggesting further near-term upward drift. FY2027 consensus revenue of $151B implies ~48% Y/Y growth from FY2026 — aggressive but grounded in the $100B AI chip framework.

• AI semiconductor at 67% of semiconductor revenue (up from ~50% a year ago), expected to hit 72% in Q2. The business has structurally shifted from diversified semi to AI-dominated.
• VMware TCV of $9.2B in Q1 — below Q4's $10.4B but Q1 is seasonally weak. ARR growing 19% Y/Y. Software guided to $7.2B in Q2 (+9% Y/Y), accelerating from Q1's +1%.
• Semiconductor operating margin at 60% (+260 bps Y/Y) with software at 78% (+190 bps Y/Y) — both showing operating leverage despite rapid AI mix shift.
• Q2 guidance: Semi $14.8B (+76% Y/Y), Software $7.2B (+9% Y/Y), Total $22.0B (+47% Y/Y).
• Non-AI flat YoY — broadband, enterprise networking, storage all stable but not recovering. This is a valuation floor, not a growth driver.

• IV crushed -6.8 pts on D+1 (56.3% → 49.6%), then rebounded to 54.2% on D+2 as SOX sold off -5% on macro/tariff concerns. Options remain expensive: ATM IV at 54% vs 30D realized vol of 39%.
• Downside skew is steep: March P300 at 72.2% vs ATM 61.0% — an 11.2 pt skew. Institutions paying up for downside hedging despite the positive earnings reaction.
• Call OI concentrated at $370-400 strikes (15-17K OI each) — significant speculative/upside positioning. $400 strike has the single highest OI in the near-term chain.
• Short interest modest: 49.9M shares, 1.8 days to cover, 1.07% of float. Not a crowded short.
• P/C OI ratio compressed from 1.21 to 1.02 into the print (put unwind / call buying), then re-expanded to 1.10 post-event.

• AVGO outperformed SOX by +9.12pp over two sessions — one of the strongest relative reactions in recent semiconductor earnings. The market clearly rewarded the forward guidance, not the modest Q1 beat.
• D+1 volume of 57.1M shares (2.53x avg) confirms heavy institutional participation on the gap-up. D+2 saw an intraday high of $343.51 (+8.2% from pre-print) before fading to $330.48 — the fade likely reflects macro drag (SOX -5%) rather than AVGO-specific selling.
• The market reacted to three specific catalysts: (1) Q2 revenue guide $1.5B above consensus, (2) $100B+ FY2027 AI chip target, (3) OpenAI as 6th customer. The Q1 beat was not the driver.
• The stock reclaimed its 200 DMA ($320.70) from below on the gap-up but remains below the 50 DMA ($334.32) and 100 DMA ($348.09). RSI at 51 is neutral. The $320-335 range is the new trading range — a break above the 50 DMA would be the first sustained bullish signal.

Consensus: 57 Buy / 3 Hold / 0 Sell out of 60 analysts (95% Buy). 44 post-print updates. Mean PT $466, Median $470 — both imply ~42% upside from $330.48. Tier 1 PT clustering at $450-$530. Zero sells. Even the most cautious mainstream targets (RBC $360, D.A. Davidson $375) imply 9-14% upside. Baird at $630 (91% upside) is the Street outlier.

• NVIDIA: AVGO's $100B+ AI chip target directly competes with NVDA data center TAM. Hock's framing of GPUs as "one-size-fits-all" vs workload-optimized XPUs is explicit competitive positioning. If 6 major AI players deploy multi-GW custom silicon, that is TAM NVDA does not capture. The $700B capex envelope is large enough for both, but the relative share trajectory is the core debate.
• Marvell: AVGO's aggressive customer disclosures put pressure on MRVL to demonstrate comparable custom silicon scale. MRVL has Amazon (Trainium) and potentially Microsoft, but Hock's emphasis on yields, time-to-market, and COT defensibility positions AVGO as the premium ASIC partner. MRVL needs to show its own pipeline at its next earnings.
• AMD: Squeezed between NVDA (better GPUs) and AVGO (better custom silicon). AMD's Xilinx-based custom silicon is not competitive with AVGO's ASIC business at hyperscaler scale.
• Hyperscaler capex thesis: Emphatically reinforced. If AVGO alone has $100B+ AI chip visibility for 2027, total hyperscaler AI capex is in the $250-350B range. Anthropic's 1→3+ GW trajectory, OpenAI ramping to 1+ GW, and customers developing two chips simultaneously (training + inference) suggest capex intensity is accelerating, not peaking.

Near-Term (Next 1-5 Trading Days)

The $100B+ FY2027 target and Q2 guide $1.5B above consensus create immediate upward pressure on estimates. Q2 consensus at $21.7B is still $337M below company guidance — residual upside. At 25.7x NTM with FY2027 EPS of $16.63, the stock trades at 19.9x next-year earnings — cheaper than NVDA, AMD, and the hyperscalers on a forward basis. The 50 DMA at $334 is the immediate resistance; reclaiming it would confirm the re-rating.

Medium-Term (Next 2-4 Quarters)

Execution against the $100B target is now the dominant monitoring variable. The Q2 print ($10.7B AI guided) is the first checkpoint — any miss or deceleration would be severely punished given the credibility stake. VMware's re-acceleration to +9% Y/Y in Q2 needs to deliver. The gross margin "hallucinating" call will be watched intensely — if Q3/Q4 margins decline, management credibility takes a hit. FY2027 consensus revenue of $151B (+48% Y/Y) embeds aggressive growth that the $100B AI chip framework supports but doesn't guarantee.

Bull Case

AVGO achieves $100B+ AI chips in FY2027, customer count expands beyond 6, AI networking sustains 40%+ of AI revenue, VMware grows double-digits and becomes the enterprise AI private cloud standard. Gross margins stabilize at 77% as yields improve. Operating leverage drives 70%+ EBITDA margins. FY2027 EPS power of $16-18 supports $350-450 stock price at current multiples, with upside if the market re-rates on demonstrated execution.

Bear Case

$100B target proves aspirational — demand peaks in H2 FY2026. Meta pursues COT in earnest, reducing AVGO content. Gross margin compression materializes from rack sales despite management denial. OpenAI XPU deployment delayed. NVDA's Rubin makes GPUs competitive enough to slow custom silicon adoption. TSMC concentration risk (Taiwan). 6-customer concentration means any single pullback is painful.

Conviction Assessment

This was a thesis-accelerating quarter. The $100B+ target, OpenAI naming, Meta MTIA defense, margin walk-back, and supply chain extension collectively exceeded reasonable bull case expectations. The debate shifts from "Is AVGO a real AI play?" to "Is $100B+ achievable and what's it worth?" — a far more constructive setup for longs. Conviction should increase materially after this print.